Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Ping An Biomedical Co's accounts receivables for the quarter that ended in Sep. 2025 was $2.38 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Ping An Biomedical Co's Days Sales Outstanding for the quarter that ended in Sep. 2025 was 194.18.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Ping An Biomedical Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2025 was $-0.06.
Ping An Biomedical Co Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Ping An Biomedical Co's Days Sales Outstanding for the quarter that ended in Sep. 2025 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Ping An Biomedical Co's accounts receivable are only considered to be worth 75% of book value:
Ping An Biomedical Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Ping An Biomedical Co Accounts Receivable Related Terms
Ping An Biomedical Co Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Ping An Biomedical Co's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Accounts Receivable of $2.38 Mil mean?
Ping An Biomedical Co (PASW) has a Accounts Receivable of $2.38 Mil as of Sep. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Ping An Biomedical Co and its competitors.
Is Ping An Biomedical Co's Accounts Receivable too high?
Ping An Biomedical Co's current Accounts Receivable is $2.38 Mil. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Accounts Receivable compare to DXYN and CULP?
Ping An Biomedical Co's Accounts Receivable of $2.38 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Manufacturing - Apparel & Accessories company?
A good Accounts Receivable depends on the Manufacturing - Apparel & Accessories industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Ping An Biomedical Co and its competitors. Ping An Biomedical Co's current Accounts Receivable is $2.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Accounts Receivable of $2.38 Mil. The current Accounts Receivable is $2.38 Mil. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Accounts Receivable is $2.38 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
